Cav1 is expressed at high levels in terminally differentiated cells and is often deregulated in cancer and fibrotic diseases.53 The deregulation of Cav1 via TGFβ, a potent fibrogenic cytokine, might disrupt tumour‐suppressive signals, thereby promoting tumour progression. This evidence concerns the gene TGFB1 and neoplasm.